Oral Cryotherapy (Ice Chips) in Oncology
Definition
- Oral cryotherapy = holding ice chips or cold water in the mouth during chemotherapy infusion.
- The cooling causes vasoconstriction of oral mucosal blood vessels → reduces drug delivery to oral epithelium.
- Goal: prevention of chemotherapy-induced oral mucositis.
Indications / Evidence
- Strong evidence for short half-life, mucotoxic agents:
- High-dose melphalan (used in autologous HSCT conditioning)
- 5-fluorouracil (5-FU) bolus administration
- NCCN & MASCC/ISOO guidelines: recommend oral cryotherapy for these situations.
Administration Protocol
- Start: 5 minutes before chemotherapy infusion.
- Continue: throughout infusion, and for ~30 minutes after completion.
- Method: Patient holds ice chips in mouth, letting them slowly melt, ensuring continuous cooling.
Benefits
- Reduces incidence and severity of oral mucositis.
- Decreases opioid analgesic use and need for parenteral nutrition in HSCT patients.
- Low cost, simple, and well tolerated.
Limitations
- Only effective for short half-life agents (melphalan, 5-FU bolus).
- Not effective for continuous infusions (e.g., 5-FU CIVI) or agents with long half-life (busulfan, cyclophosphamide, TBI).
- Some patients find it uncomfortable (cold intolerance, dental sensitivity).
- Contraindicated in patients with cold agglutinin disease.
Pharmacist Pearls
- Reinforce adherence: patient must actively swish and keep ice in contact with oral mucosa.
- Combine with other mucositis-prevention strategies when needed (palifermin, good oral hygiene).
- Educate that cryotherapy is preventive, not therapeutic — less effective once mucositis has already developed.
So in short: Ice chips = first-line, inexpensive, evidence-based supportive care for prevention of mucositis in high-dose melphalan and bolus 5-FU regimens.